BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10903525)

  • 21. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal contraception and cancer.
    Drife J; Guillebaud J
    Br J Hosp Med; 1986 Jan; 35(1):25-9. PubMed ID: 3955285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contraceptive strategies for reducing the risk of reproductive cancers.
    Aliabadi AR; Wilailak S; McNally O; Berek JS; Sridhar A; ;
    Int J Gynaecol Obstet; 2024 Jul; 166(1):141-151. PubMed ID: 38725288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral contraceptive use and risk of cancer--letter.
    Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):676. PubMed ID: 24636972
    [No Abstract]   [Full Text] [Related]  

  • 25. OCs and genital tract malignancies.
    Herbst AL
    Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian and endometrial function during hormonal contraception.
    ESHRE Capri Workshop Group
    Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.
    Kelsey JL; Whittemore AS
    Ann Epidemiol; 1994 Mar; 4(2):89-95. PubMed ID: 8205289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives.
    Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
    Aust N Z J Public Health; 2015 Oct; 39(5):441-5. PubMed ID: 26437729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone prevention strategies for breast, endometrial and ovarian cancers.
    Rice LW
    Gynecol Oncol; 2010 Aug; 118(2):202-7. PubMed ID: 20471672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoplasia and hormonal contraception.
    Huggins GR
    Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-contraceptive benefits of oral contraceptives.
    Huber JC; Bentz EK; Ott J; Tempfer CB
    Expert Opin Pharmacother; 2008 Sep; 9(13):2317-25. PubMed ID: 18710356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraception and cancer of the female reproductive system.
    Woods KL
    J Clin Hosp Pharm; 1985 Jun; 10(2):123-35. PubMed ID: 3894428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal contraception and risk of cancer.
    Cibula D; Gompel A; Mueck AO; La Vecchia C; Hannaford PC; Skouby SO; Zikan M; Dusek L
    Hum Reprod Update; 2010; 16(6):631-50. PubMed ID: 20543200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptives and reproductive system cancer.
    Deligeoroglou E; Michailidis E; Creatsas G
    Ann N Y Acad Sci; 2003 Nov; 997():199-208. PubMed ID: 14644827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
    Schlesselman JJ
    Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cancers and contraceptive pill: the CNGOF, the FNCGM and the SFG answer the CIRC].
    Serfaty D; Boutet G; Lansac J; Lopès P
    Gynecol Obstet Fertil; 2006 Feb; 34(2):92-3. PubMed ID: 16497533
    [No Abstract]   [Full Text] [Related]  

  • 38. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
    Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
    Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
    Jalil NA; Zin AA; Othman NH
    Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
    Vessey M; Yeates D
    Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.